ArticleTransplantation direct2023

Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients.

Cary M Looney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.